Skip to main content
Clinical Trials/IRCT20210718051928N1
IRCT20210718051928N1
Recruiting
Phase 2

Comparison of three drug groups effectiveness, intravenous Lidocaine and Dexamethasone, intravenous Ketamine and Dexamethasone and Dexamethasone alone in the managment of respiratory complications after tonsillectomy.

Esfahan University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Respiratory complications after tonsillectomy.
Sponsor
Esfahan University of Medical Sciences
Enrollment
100
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All ASA1 patients are candidates for elective tonsillectomy
  • Age between 2\-18 years
  • Parental consent

Exclusion Criteria

  • Active upper respiratory tract infection during the two weeks prior to surgery
  • Active lower respiratory tract infection during the 5 weeks prior to surgery
  • History of asthma
  • History of allergy to Lidocaine , Dexamethasone and Ketamine
  • ASA2 patients and higher

Outcomes

Primary Outcomes

Not specified

Similar Trials